Literature DB >> 30378106

Tumor microenvironment: Interactions and therapy.

Masoud Najafi1, Nasser Hashemi Goradel2, Bagher Farhood3, Eniseh Salehi4, Somaye Solhjoo4, Heidar Toolee4, Ebrahim Kharazinejad5, Keywan Mortezaee6.   

Abstract

Tumor microenvironment (TME) is a host for a complex network of heterogeneous stromal cells with overlapping or opposing functions depending on the dominant signals within this milieu. Reciprocal paracrine interactions between cancer cells with cells within the tumor stroma often reshape the TME in favor of the promotion of tumor. These complex interactions require more sophisticated approaches for cancer therapy, and, therefore, advancing knowledge about dominant drivers of cancer within the TME is critical for designing therapeutic schemes. This review will provide knowledge about TME architecture, multiple signaling, and cross communications between cells within this milieu, and its targeting for immunotherapy of cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer cell; cancer-associated fibroblast; cytotoxic T lymphocyte; exosome; extracellular matrix; hypoxia; immunosuppression; interaction (cross-talk); regulatory T; tumor microenvironment; tumor-associated macrophage

Mesh:

Substances:

Year:  2018        PMID: 30378106     DOI: 10.1002/jcp.27425

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  57 in total

1.  Viral Nanoparticles: Cancer Vaccines and Immune Modulators.

Authors:  Manlio Fusciello; Erkko Ylösmäki; Vincenzo Cerullo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma.

Authors:  Hongfang Zhang; Jingxing Si; Jing Yue; Shenglin Ma
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-09       Impact factor: 4.553

3.  Impact of Collagen Triple Helix Structure on Melanoma Cell Invadopodia Formation and Matrix Degradation upon BRAF Inhibitor Treatment.

Authors:  Della S Shin; Megan E Schroeder; Kristi S Anseth
Journal:  Adv Healthc Mater       Date:  2021-11-25       Impact factor: 9.933

Review 4.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

5.  TRIM24 promotes colorectal cancer cell progression via the Wnt/β-catenin signaling pathway activation.

Authors:  Hong Tian; Hongmei Zhao; Bo Qu; Xiaoli Chu; Xing Xin; Qingwei Zhang; Weizhou Li; Shida Yang
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 6.  CXCL12 Signaling in the Tumor Microenvironment.

Authors:  Luigi Portella; Anna Maria Bello; Stefania Scala
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression.

Authors:  Asurayya Worrede; Stephen M Douglass; Ashani T Weeraratna
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 8.  Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment.

Authors:  María Belén Giorello; Francisco Raúl Borzone; Vivian Labovsky; Flavia Valeria Piccioni; Norma Alejandra Chasseing
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-04       Impact factor: 2.673

Review 9.  The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.

Authors:  Yanghong Ni; Xiaoting Zhou; Jia Yang; Houhui Shi; Hongyi Li; Xia Zhao; Xuelei Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-20

10.  Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy.

Authors:  Masoud Delfi; Rossella Sartorius; Milad Ashrafizadeh; Esmaeel Sharifi; Yapei Zhang; Piergiuseppe De Berardinis; Ali Zarrabi; Rajender S Varma; Franklin R Tay; Bryan Ronain Smith; Pooyan Makvandi
Journal:  Nano Today       Date:  2021-03-11       Impact factor: 18.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.